Pricing - HEOR - Access
Our market access related courses aim to accelerate your learning curve in disciplines that are critical in the process of optimising market access, and even patient access.
Get up to speed in no time with CELforPharma’s 1- & 2-day courses by international industry experts in:
➙ Market Access in Europe
➙ Value Pricing
➙ Real World Evidence
➙ Health Economics
➙ Market Access for Orphan Drugs
➙ Health Technology Assessment
Understanding Pharma Market Access & Payers in Europe
By Dr. Nick Proctor
In this 1-day course, you will learn:
The patterns in pricing & reimbursement systems and processes in France, Germany, Italy, Spain and the UK.
Payer archetypes and the drivers of their decision-making processes
The market access plan and process, and the contributions of internal stakeholders across functions.
...
How to Price Better Than Your Competitors for Successful Market Access
Essential Insights, Principles & Techniques
By Gary Johnson & Sam Johnson
In this 2-day course, you will learn:
An overview of payer types and of national pricing & market access systems around the world.
The concepts and language of pharma pricing and market access that confuse many executives.
Evidence-based research techniques for getting the most accurate feedback from payers about your product’s profile.
...
Generating RWE for Optimising Market/Patient Access
By Dr. Marco Ghiani & Prof. Dr. Thomas Wilke
In this 1-day course, you will learn:
The expectations of external stakeholders regarding RWE along the product lifecycle
The fundamental concepts, methodologies and research techniques of RWE in the context of optimising Market Access
Critical success factors of a RWE study
...
Learn the Fundamentals of Health Economics
By Prof. Dr. Lieven Annemans
The logic and math behind QALYs, ICERs, decision-trees and Markov models.
How external stakeholders use and challenge health economic evidence.
Key principles of cost-effectiveness analysis and Budget Impact Analysis.
...
During a 2-day Face-to-Face Course:
Health Economics for Non-Health-Economists
OR
In an Online Self-Study Programme:
Basics of Health Economics
Strategic Market Access Planning for Orphan Drugs
By Dr. Paul Craddy & Dr. Graham Foxon
In this 1-day course, you will learn:
The current status of payer attitudes and HTAs for orphan drugs.
Guidelines for developing and implementing an optimal market access strategy for orphan drugs: timelines, country customisation, value pricing…
Which evidence you need and how to develop a convincing value proposition that will meet payers’ and regulators’ needs and thus secure timely patient access at a sustainable price.
...
How to Optimally Manage HTA Criteria & Processes in Europe
Best Practices, Trends & Opportunities
By Prof. Dr. Lieven Annemans
In this 1-day course, you will learn:
The differences in key decision-making processes and practices of HTA bodies across Europe.
The solutions to the most common problems and mistakes when optimising the quality of the evidence.
The evolution of HTA processes across the EU and opportunities to work effectively with the HTA bodies.
...
We also offer virtual 0,5-day courses that address more advanced/focused topics.
Unlike the above 1- & 2-day courses, the audience size at these 0,5-day courses is not limited and they do not include complex group work sessions.
The 0,5 day courses are listed in the COURSE FINDER, along with all other courses.
Are you ready to take your career in the pharmaceutical industry to the next level?
Discover CELforPharma's complete course portfolio, including topics you work on in cross-functional teams: